← Back to Search

Omega 3 Fatty Acid

OmegaD for Dry Eye Syndrome

Phase 3
Waitlist Available
Research Sponsored by OmegaD LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 84 days
Awards & highlights

Study Summary

This is a phase 3 study to evaluate the safety and efficacy of OmegaD softgels for the treatment of dry eye disease. A daily dose of 2 OmegaD softgels dosed orally BID will be compared to 2 placebo softgels (mineral oil ) dosed orally BID for 84 days. Approximately 300 subjects will be evaluated for their signs and symptoms of dry eye disease and for safety throughout the study.

Eligible Conditions
  • Dry Eye Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~84 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 84 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ocular Surface Disease Index (OSDI)
Tear Osmolarity
Secondary outcome measures
Schirmers Test
Tear Break Up Time (TBUT)
Other outcome measures
Meibomian Gland Dysfunction (MGD)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: OmegaDExperimental Treatment1 Intervention
OmegaD Softgels
Group II: PlaceboPlacebo Group1 Intervention
Placebo Softgels
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Omega 3 fatty acid
2017
Completed Phase 4
~420

Find a Location

Who is running the clinical trial?

OmegaD LLCLead Sponsor
1 Previous Clinical Trials
180 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Georgia
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Phase 3 Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
2019. "Phase 3 Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04181593.
All > Dry Eye
~59 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top